ArticleInvestigational new drugs2013

UGT1A1 genotype-guided phase I study of irinotecan, oxaliplatin, and capecitabine.

Matthew P Goetz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.